RNF43 and colorectal adenocarcinoma: We further investigated the evidence of RNF43 truncating mutations being associated with MAPK/RTK pathway activation in primary colorectal adenocarcinoma by incorporating the more expansive RNF43 mutation calls identified with manual review from Giannakis et.